Inman Jager Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.31M Buy
54,399
+5,434
+11% +$142K 0.7% 44
2026
Q1
$1.37M Buy
48,965
+3,283
+7% +$87.4K 0.8% 43
2025
Q4
$1.14M Buy
45,682
+4,693
+11% +$118K 0.7% 45
2025
Q3
$1.04M Buy
40,989
+905
+2% +$22.3K 0.67% 46
2025
Q2
$972K Buy
40,084
+5,124
+15% +$119K 0.66% 45
2025
Q1
$886K Buy
34,960
+12,095
+53% +$316K 0.66% 47
2024
Q4
$607K Buy
+22,865
New +$620K 0.47% 54

Other funds holding PFE

Inman Jager Wealth Management's PFE Position: Q2 2026 in Review

Inman Jager Wealth Management increased its Pfizer (PFE) stake by 11% in Q2 2026, buying an estimated $142K and bringing the position to 54,399 shares worth $1.31M. The position accounts for 0.7% of the portfolio, ranked #44.

Inman Jager Wealth Management first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.37M in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Inman Jager Wealth Management held 54,399 shares of Pfizer worth $1.31M as of Q2 2026.
  • Inman Jager Wealth Management bought 5,434 Pfizer shares in Q2 2026, an estimated $142K.
  • Pfizer made up 0.7% of Inman Jager Wealth Management's portfolio in Q2 2026, its #44 holding.
  • Inman Jager Wealth Management first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Inman Jager Wealth Management's Pfizer position peaked at $1.37M in Q1 2026.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Inman Jager Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.